Tuesday, September 20th 2022
7:00 p.m. to 8:00 p.m.
Virtual

Summary:

This webinar will discuss the FDA’s postmarketing drug safety surveillance activities, how adverse event reports are collected and analyzed by FDA and how safety findings are communicated to the public.

Learning Objectives:

1. Describe FDA’s postmarketing drug safety surveillance system
2. Identify the components of postmarketing reporting and signal detection
3. Summarize how adverse event reports are collected and analyzed by FDA
4. Describe how safety findings are communicated to the public

Activity Type: Knowledge
Contact Hours: 1.0

Presenter:

Heather Le, PharmD
Safety Evaluator
USFDA

Registration Rates:

VPhA Members: FREE
Non-Members: $10

The Zoom link will be sent out to all registered attendees on the 20th
Registration is now closed.